FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

421203005: Tenofovir disoproxil (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2614923016 Tenofovir disoproxil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2617553010 Tenofovir disoproxil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
369891000195113 tenofovir disoproxil it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
844231000172114 ténofovir disoproxil fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tenofovir disoproxil (substance) Is a Tenofovir (substance) false Inferred relationship Some
Tenofovir disoproxil (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Reverse transcriptase inhibitor (disposition) true Inferred relationship Some
Tenofovir disoproxil (substance) Is a Transferase inhibitor false Inferred relationship Some
Tenofovir disoproxil (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tenofovir (substance) true Inferred relationship Some
Tenofovir disoproxil (substance) Is a Carboxylic ester (substance) true Inferred relationship Some
Tenofovir disoproxil (substance) Is a Reverse transcriptase inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 1
Tenofovir disoproxil fumarate (substance) Is a False Tenofovir disoproxil (substance) Inferred relationship Some
Tenofovir disoproxil fumarate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tenofovir disoproxil (substance) Inferred relationship Some
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 2
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 3
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 2
Tenofovir disoproxil maleate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tenofovir disoproxil (substance) Inferred relationship Some
Tenofovir disoproxil phosphate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tenofovir disoproxil (substance) Inferred relationship Some
Tenofovir disoproxil succinate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tenofovir disoproxil (substance) Inferred relationship Some
Doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 2
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 2
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 2
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 3
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 3
Tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 1
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tenofovir disoproxil (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start